Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5466]

ASH 2012: First curative treatment for acute promyelocytic leukaemia that does not include chemotherapy

ASH 2012: First curative treatment for acute promyelocytic leukaemia that does not include chemotherapy

$ASH 2012: Ibrutinib promotes high response rate in treatment naïve and relapsed or refractory chronic lymphocytic leukaemia$

ASH 2012: Ibrutinib promotes high response rate in treatment naïve and relapsed or refractory chronic lymphocytic...

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Molecular ‘portraits’ of tumours match patients with trials in everyday clinical practice

Molecular ‘portraits’ of tumours match patients with trials in everyday clinical practice

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway

New targeted therapy for advanced prostate cancer shows anti-tumour activity in phase I clinical trials

New targeted therapy for advanced prostate cancer shows anti-tumour activity in phase I clinical trials

Scientists test 5000 combinations of 100 existing cancer drugs to find more effective treatments

Scientists test 5000 combinations of 100 existing cancer drugs to find more effective treatments

NCRI 2012: Highlights from Monday 5 November

NCRI 2012: Highlights from Monday 5 November

NCRI 2012: Highlights from Sunday 4 November

NCRI 2012: Highlights from Sunday 4 November

Researchers identify biomarkers of aggressive behavior and therapeutic targets for adult B-acute lymphoblastic leukaemia

Researchers identify biomarkers of aggressive behavior and therapeutic targets for adult B-acute lymphoblastic...

More from ecancer